APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

• Jing Qian,

  Affiliation Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America

  ⨯
• Frank J. Wolters,

  Affiliation Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands

  http://orcid.org/0000-0003-2226-4050

  ⨯
• Alexa Beiser,

  Affiliations Department of Neurology, Boston University Medical School, Boston, Massachusetts, United States of America, Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Mary Haan,

  Affiliation Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

  http://orcid.org/0000-0001-9312-4501

  ⨯
• M. Arfan Ikram,

  Affiliation Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands

  ⨯
• Jason Karlawish,

  Affiliation Department of Medicine, University of Pennsylvania Medical School, Philadelphia, Pennsylvania, United States of America

  ⨯
• Jessica B. Langbaum,

  Affiliation Banner Alzheimer’s Institute, Phoenix, Arizona, United States of America

  ⨯
• John M. Neuhaus,

  Affiliation Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Eric M. Reiman,

  Affiliations Banner Alzheimer’s Institute, Phoenix, Arizona, United States of America, Department of Psychiatry, University of Arizona College of Medicine, Phoenix, Arizona, United States of America, Arizona State University–Banner Neurodegenerative Disease Research Center, Tempe, Arizona, United States of America, Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona, United States of America

  ⨯
• J. Scott Roberts,

  Affiliation Department of Health Behavior & Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America

  ⨯
• Sudha Seshadri,

  Affiliation Department of Neurology, Boston University Medical School, Boston, Massachusetts, United States of America

  ⨯
• Pierre N. Tariot,

  Affiliations Banner Alzheimer’s Institute, Phoenix, Arizona, United States of America, Department of Psychiatry, University of Arizona College of Medicine, Phoenix, Arizona, United States of America

  ⨯
• Beth McCarty Woods,

  Affiliation Department of Medicine, University of Pennsylvania Medical School, Philadelphia, Pennsylvania, United States of America

  ⨯
• Rebecca A. Betensky,

  Affiliation Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Deborah Blacker

  * E-mail: blacker@psych.mgh.harvard.edu

  Affiliations Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  http://orcid.org/0000-0001-6107-7376

  ⨯